Helminth Infections

FDA Approves New Treatment for Onchocerciasis

By June 14, 2018

Moxidectin, a macrocyclic lactone, is an anthelmintic drug that selectively binds to the parasite's glutamate-gated chloride ion channels.

First Treatment for Chagas Disease Gets FDA Approval

By August 30, 2017

Chagas disease, also known as American trypanosomiasis, is caused by the Trypanosoma cruzi parasite.

Cases of Cyclosporiasis on the Rise, CDC Warns

By August 08, 2017

A total of 206 cases of Cyclospora infections have been reported to the CDC as of August 2, 2017 among individuals who became ill on or after May 1, 2017.

Warm Autoimmune Hemolytic Anemia Occurs After Babesiosis

March 10, 2017

The researchers documented warm autoimmune hemolytic anemia following babesiosis in patients with no history of autimmunity, they said there was no alternative explanation for clinical hemolysis.

Emverm Chewable Tabs Available for Pinworm Treatment

By March 31, 2016

Emverm (mebendazole; Impax) chewable tablets are available for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections. It is indicated for use in both adults and children

FDA Approves Emverm Chewable Tablets

By January 15, 2016

Impax announced that the Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for Emverm (mebendazole) chewable tablets.

Nobel Prize Awarded for Groundbreaking Research on Infectious Disease Drugs

By October 05, 2015

The Nobel Assembly at Karolinska Institutet has awarded the 2015 Nobel Prize in Physiology or Medicine to researchers for their discoveries concerning novel therapies against infections caused by roundworm parasites and malaria.

New Government Policies on Pathogen Research Issued, But Will They Be Effective?

September 25, 2014

New policy guidelines issued by the White House Office of Science and Technology Policy are calling for U.S. universities to carefully monitor their life sciences research on dangerous pathogens and toxins for both benefits and risks.

Tick Vector of Heartland Virus Identified

July 23, 2013

The tick Amblyomma americanum has been identified as the vector of the heartland virus (HRTV), the first pathogenic Phlebovirus (Family: Bunyaviridae).

New Tickborne Illness Identified in Northern U.S.

July 02, 2013

Tick-exposed patients should also be analyzed for evidence of infection with the newly recognized spirochete Borrelia miyamotoi.

CDC: About 20,000 Cases of Foodborne Infection in 2012

April 22, 2013

There were about 20,000 cases of foodborne infection in 2012, with the highest incidence among young children and the greatest proportion of hospitalizations and deaths among the elderly.

Tapeworm Infections Rise in U.S.; Treatment Guidelines Issued

April 09, 2013

Adults and children with intraparenchymal neurocysticercosis, a tapeworm infection causing seizures most commonly in developing countries of Africa, Asia, and Latin America, should be treated with albendazole plus either dexamethasone or prednisolone.

ACAAI: Much of Alpha-Gal Sensitivity Due to Lone Star Tick

November 09, 2012

Although rates of galactose-alpha-1,3-galactose (alpha-gal) immunoglobulin (Ig)E sensitization are higher in areas where the lone star tick is known to exist, alpha-gal sensitization is also seen in regions without the lone star tick.